Cargando…
Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?
Dopamine and its receptors are currently recognized targets for the treatment of several neuropsychiatric disorders, including Parkinson’s disease, schizophrenia, some drug use addictions, as well as depression. Dopamine receptors are widely distributed in various regions of the brain, but their rol...
Autores principales: | Zhao, Fangyi, Cheng, Ziqian, Piao, Jingjing, Cui, Ranji, Li, Bingjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428607/ https://www.ncbi.nlm.nih.gov/pubmed/36059987 http://dx.doi.org/10.3389/fphar.2022.947785 |
Ejemplares similares
-
Rasd2 Mediates Acute Fasting-Induced Antidepressant-Like Effects via Dopamine
D2 Receptor Activation in Ovariectomized Mice
por: Cheng, Ziqian, et al.
Publicado: (2023) -
Changes in Hippocampal Plasticity in Depression and Therapeutic Approaches Influencing These Changes
por: Xu, Wenbo, et al.
Publicado: (2020) -
Leptin in depression: a potential therapeutic target
por: Ge, Tongtong, et al.
Publicado: (2018) -
Transcription factors are potential therapeutic targets in epilepsy
por: Sun, Qihan, et al.
Publicado: (2022) -
Effects of Electroconvulsive Therapy on Depression and Its Potential Mechanism
por: Li, Ming, et al.
Publicado: (2020)